A CLINICAL TRIAL TO STUDY THE EFFECTS OF TEO DRUGS, VIMALA VARTI ANJANA AND PIPPALYADI ANJANA IN PATIENTS WITH SIMPLE MYOPIA

A COMPARATIVE STUDY TO EVALUATE THE EFFICACY OF VIMALA VARTI ANJANA AND PIPPALYADI ANJANA IN PRATHAMA PATALAGATA TIMIRA (SIMPLE MYOPIA)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/05/033878

Enrollment

Registered

2021-05-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

Intervention1: VIMALA VARTI ANJANA: ANJANA IS TAKEN IN THE RING FINGER OF THE RIGHT HAND AND APPLIED FROM INNER TO OUTER SIDE OF THE LOWER EYE LID FOR 48 DAYS.THE LEFT HAND IS USED TO STRETCH THE EYE.

Eligibility

Inclusion criteria

Inclusion criteria: Patients fulfilling the diagnostic criteria Patients between the age group of 10-21 years Patients having dioptric power less than -6D Patients who are fit for Anjana

Exclusion criteria

Exclusion criteria: Patients with Dwitheeya, Tritheeya and Chathurtha Patalagata Timira Patients having other refractive errors except simple myopia Anjana Anarha Patients with other systemic disorders that may interfere with the study Patients with H/O ocular trauma and surgeries Patients with other ocular pathologies

Design outcomes

Primary

Measure	Time frame
1 Defective distant vision 2 Asthenopic symptoms Head ache Watering of eyes Blurring of vision 3 Snellenâ??s distant vision chart 4 Auto refractive reading Timepoint: 144 DAYS	—

Secondary

Measure	Time frame
not applicableTimepoint: not applicable	—

Countries

India

Contacts

Public ContactDR APEKSHA D RAO

ALVAS AYURVEDA MEDICAL COLLEGE AND HOSPITAL

drapekshadrao@gmail.com7411360991

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026